Ligand validation:6G30

ADP: ADENOSINE-5'-DIPHOSPHATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6G30_ADP_A_807	57%	33%	0.191	0.966	1.35	1.29	3	3	0	0	100%	1
6G2X_ADP_A_809	90%	41%	0.105	0.987	0.93	1.34	1	2	0	0	100%	1
6G2Z_ADP_A_807	77%	47%	0.129	0.968	0.97	1.06	2	2	0	0	100%	1
6G2Y_ADP_A_807	76%	38%	0.143	0.981	1.08	1.34	3	3	0	0	100%	1
6G2W_ADP_A_807	64%	38%	0.167	0.966	1.1	1.31	1	2	2	0	100%	1
3CF0_ADP_L_900	63%	21%	0.165	0.962	1.56	1.73	2	6	3	0	100%	1
3KB1_ADP_B_301	100%	23%	0.023	0.994	2.02	1.19	7	4	1	0	100%	1
5GZA_ADP_A_401	100%	2%	0.019	0.997	3.36	3.39	13	11	1	0	100%	1
5KHW_ADP_A_1201	100%	41%	0.023	0.995	1.1	1.2	1	2	0	0	100%	1
8VZA_ADP_A_603	100%	37%	0.024	0.995	0.96	1.51	1	5	0	0	100%	1
1PHP_ADP_A_396	100%	24%	0.026	0.995	1.29	1.8	3	11	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.